advertisement
Saeedi OJ 22
Showing records 1 to 22 | Display all abstracts from Saeedi OJ84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Wang M
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Tracey BM
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Tichelaar J
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Mayo LN; Le CT
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Pasquale LR; Shen LQ
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Chen VY; Weichsel J
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Boland MV; Wellik SR
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Renner CY; Li J
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
De Moraes CG
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Tsai JJ
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Myers JS; Ramulu P
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Kalarn SP
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Kwon M
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Ou MT; Chang LY
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Saeedi OJ
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Mohammed TK
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Wang H; Baniasadi N
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Mohammed ISK; Shah KA
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Li D; Bex PJ
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Thompson GM; Jones AMK
Scientific reports 2019; 9: 20178
84857 Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence
Elze T
JAMA ophthalmology 2020; 0:
84825 Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry
Im LT; Kaleem MA; Saeedi OJ
Scientific reports 2019; 9: 20178
